[TOVX] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
31-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 13.78%
YoY- -211.33%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,263 -2,132 -3,144 -3,192 2,812 -2,472 -11,297 -11.94%
Tax -13 -23 -4 -85 -8,633 -7,829 -411 -43.73%
NP -5,263 -2,109 -3,140 -3,173 2,850 -2,375 -10,982 -11.52%
Tax Rate - - - - 307.01% - - -
Total Cost 5,263 2,109 3,140 3,173 -2,850 2,375 10,982 -11.52%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.40 -1.00 -1.87 -2.05 7.70 -8.00 -42.28 -53.97%
EPS Diluted -0.40 -1.00 -1.87 -2.05 7.70 -7.09 -42.28 -53.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.